Apple says new CareKit platform will ‘empower’ Parkinson’s patients
Author: Geoffrey ChangPublished: 24 March 2016
Prep: Cook: Serves:
People with Parkinson’s will be among the first to experience the benefits of Apple’s new open-source health-tracking platform, which will ‘empower’ patients – and could transform the way we think about health
Apple has revealed a new health-tracking software platform at its ‘Loop You In’ product launch event. CareKit is a software framework designed for apps that let people with Parkinson’s and other chronic diseases better understand and manage their condition.
With the introduction of the platform, Apple aims to put patients back in charge of tracking symptoms and medications with the use of a smartphone.
Though CareKit won’t be fully available until next month, one of the apps to have first access to the platform is for people with Parkinson’s, and will monitor the effectiveness of medication used to treat the condition.
Jeff Williams, Chief Operating Officer of Apple, said: “We believe that giving individuals the tools to understand what is happening with their health is incredibly powerful. Apps designed using CareKit make this a reality by empowering people to take a more active role in their care.”
After the success of ResearchKit, the study-focused platform that enabled medical researchers to gather highly individualised data on a large-scale, Apple decided to widen the scope from medical research to personal care with the development of CareKit.
Developed by Sage Bionetworks and the University of Rochester, the first app built for ResearchKit was mPower, which claims to be responsible for the biggest Parkinson’s study to date.
Dr Stephen Friend, president of Sage Bionetworks, said: “mPower allows researchers to follow day-to-day fluctuations in Parkinson’s disease symptoms and allows for insights that would be impossible to achieve when a patient is only being examined every six months.
“This kind of data has never been tracked and captured before, and now with the help of CareKit, we can provide quantitative insights to inform the dialogue a person has with a health professional about his or her own disease.”
CareKit will be available in April. For more information click here
How CareKit could benefit people with Parkinson’s
Apps built for CareKit will be able to utilise specialised ‘modules’ such as the so-called ‘Care Card’, ‘Insight Dashboard’, ‘Symptoms and Measurement tracker’ and ‘Connect’.
Here’s how the modules could work with Parkinson’s apps:
‘Care Card’ keeps tabs on your medication or physical therapy needs, essentially creating interactive to-do lists that remind you when to take your medicine.
‘Insight Dashboard’ maps progress over time and can reveal which treatments are actually working in relation to symptom fluctuation.
‘Symptoms and Measurement tracker’takes advantage of the iPhone’s high-tech sensory capabilities such as accelerometers, microphones, gyroscopes, cameras and GPS. For example, the phone’s microphone can record and analyse the subtle changes in the voice of Parkinson’s patients, or the gyroscope and accelerometers can sense a range of motions like fluctuations in gait.
‘Connect’ allows all this information to be shared with doctors, healthcare teams and family members.
Coronavirus vaccines: key facts for people with Parkinson’s disease
Experts recommend the vaccinations for those with the condition
6 days ago
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”
Could a specialised smartwatch support people with Parkinson’s disease?
A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…